Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomized, placebo-controlled trial. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.